Concourse Financial Group Securities’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-443
Closed -$10K 1545
2024
Q4
$10K Buy
443
+2
+0.5% +$40 ﹤0.01% 1719
2024
Q3
$8.03K Sell
441
-72
-14% -$1.37K ﹤0.01% 1749
2024
Q2
$8.91K Hold
513
﹤0.01% 1713
2024
Q1
$10K Buy
513
+248
+94% +$5.24K ﹤0.01% 1701
2023
Q4
$6.1K Sell
265
-168
-39% -$3.76K ﹤0.01% 1800
2023
Q3
$9.96K Buy
433
+26
+6% +$661 ﹤0.01% 1641
2023
Q2
$10.6K Buy
+407
New +$10.7K ﹤0.01% 1632

Other funds holding PRVA

Concourse Financial Group Securities's PRVA Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Privia Health (PRVA) in Q1 2025, closing a stake of 443 shares — an estimated $10K sold.

Concourse Financial Group Securities first reported a position in PRVA in Q2 2023 and held it in 7 quarters. The position peaked at $10.6K in Q2 2023. 248 funds tracked by Wall St. Rank hold PRVA as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Privia Health position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 443 Privia Health shares in Q1 2025, an estimated $10K.
  • Concourse Financial Group Securities first reported a position in Privia Health in Q2 2023 and held it in 7 quarters.
  • Concourse Financial Group Securities's Privia Health position peaked at $10.6K in Q2 2023.
  • 248 funds tracked by Wall St. Rank held Privia Health as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.